Toronto, Ontario--(Newsfile Corp. - June 6, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate care communities, today announced that the nominees listed in the Management Information Circular for the Annual General Meeting of Shareholders (the "Meeting"), which was held on June 5, 2025, were elected as directors of the Company. In addition, all other resolutions put to vote at the Meeting were passed.
The results of the vote for the election of directors at the Meeting are as follows:
Nominees | Votes For |
Kevin Dalton | 31,081,208 (99.808%) |
Ralph Desando | 31,099,751 (99.868%) |
Puneet Khanna | 31,117,133 (99.924%) |
Jason Maguire | 31,030,902 (99.647%) |
Bruce Moody | 31,124,633 (99.948%) |
Maria Perrella | 31,104,459 (99.883%) |
Jeff Watson | 31,124,633 (99.948%) |
About CareRx Corporation
CareRx is Canada's leading provider of pharmacy services to seniors living and other congregate care communities (long-term care homes, retirement homes, assisted living facilities and group homes). We are a national organization with a large network of pharmacy fulfillment centers strategically located across the country. This allows us to deliver medications in a timely and cost-effective manner and quickly respond to routine changes in medication management. We use best-in-class technology that automates the preparation and verification of multi-dose compliance packaging of medication, providing the highest levels of safety and adherence for individuals with complex medication regimens. We take an active role in working with our home operator partners to promote resident health, staff education, and medication system quality and efficiency.
For additional information, please contact:
Puneet Khanna President & Chief Executive Officer CareRx Corporation 416-927-8400 | Suzanne Brand Chief Financial Officer CareRx Corporation 416-927-8400 | Neil Weber Investor Relations LodeRock Advisors 647-222-0574 This email address is being protected from spambots. You need JavaScript enabled to view it. |
Last Trade: | C$2.90 |
Daily Change: | 0.04 1.40 |
Daily Volume: | 18,275 |
Market Cap: | C$184.120M |
May 07, 2025 March 05, 2025 November 08, 2024 August 08, 2024 May 10, 2024 |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREAmneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load